Dr. Renganathan Srinivasan, M.D

NPI: 1396841169
Total Payments
$6,425
2023 Payments
$29.53
Companies
7
Transactions
11
Medicare Patients
431
Medicare Billing
$31,744

Payment Breakdown by Category

Consulting$4,555 (70.9%)
Other$1,250 (19.5%)
Food & Beverage$619.94 (9.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $4,555 3 70.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,250 1 19.5%
Food and Beverage $619.94 7 9.6%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $2,828 3 $0 (2019)
ALK-Abello, Inc $1,381 2 $0 (2018)
Grifols USA, LLC $1,152 2 $0 (2022)
BioCryst Pharmaceuticals, Inc. $875.00 1 $0 (2020)
BioCryst US Sales Co., LLC $110.00 1 $0 (2021)
AstraZeneca Pharmaceuticals LP $50.00 1 $0 (2021)
Blueprint Medicines Corporation $29.53 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $29.53 1 Blueprint Medicines Corporation ($29.53)
2022 $1,152 2 Grifols USA, LLC ($1,152)
2021 $160.00 2 BioCryst US Sales Co., LLC ($110.00)
2020 $875.00 1 BioCryst Pharmaceuticals, Inc. ($875.00)
2019 $2,710 2 GlaxoSmithKline, LLC. ($2,710)
2018 $1,499 3 ALK-Abello, Inc ($1,381)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
08/04/2023 Blueprint Medicines Corporation AYVAKIT (Drug) Food and Beverage In-kind items and services $29.53 General
Category: Oncology / Rare Diseases
02/14/2022 Grifols USA, LLC Xembify (Biological) Consulting Fee Cash or cash equivalent $1,080.00 General
Category: Immunology and Neurology
02/07/2022 Grifols USA, LLC Xembify (Biological) Food and Beverage In-kind items and services $71.52 General
Category: Immunology and Neurology
10/16/2021 BioCryst US Sales Co., LLC Orladeyo (Drug) Food and Beverage In-kind items and services $110.00 General
Category: Immunology
10/16/2021 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $50.00 General
08/11/2020 BioCryst Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $875.00 General
11/13/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Consulting Fee Cash or cash equivalent $2,600.00 General
Category: RESPIRATORY
10/04/2019 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $110.00 General
Category: RESPIRATORY
01/27/2018 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $117.71 General
Category: RESPIRATORY
01/21/2018 ALK-Abello, Inc Odactra (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,250.00 General
Category: Allergy and Immunology
01/21/2018 ALK-Abello, Inc Odactra (Drug) Food and Beverage In-kind items and services $131.18 General
Category: Allergy and Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 63 69 $20,379 $3,909
2022 5 98 303 $29,543 $6,463
2021 5 131 433 $44,144 $11,165
2020 7 139 623 $43,215 $10,207
Total Patients
431
Total Services
1,428
Medicare Billing
$31,744
Procedure Codes
21

All Medicare Procedures & Services

21 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 20 24 $9,912 $1,811 18.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 18 18 $6,516 $1,314 20.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 13 $3,809 $680.39 17.9%
36415 Insertion of needle into vein for collection of blood sample Office 2023 12 14 $142.00 $103.63 73.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 25 27 $11,178 $2,383 21.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 27 27 $9,693 $2,139 22.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 19 19 $5,548 $982.84 17.7%
86003 Measurement of antibody (ige) to allergic substance, crude allergen extract, each Office 2022 14 214 $2,996 $911.20 30.4%
36415 Insertion of needle into vein for collection of blood sample Office 2022 13 16 $128.00 $47.49 37.1%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 36 36 $12,096 $3,124 25.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 28 32 $10,784 $2,502 23.2%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 20 20 $10,180 $2,319 22.8%
86003 Measurement of antibody (ige) to allergic substance, crude allergen extract, each Office 2021 23 319 $5,104 $1,665 32.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 24 26 $5,980 $1,554 26.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 29 36 $12,132 $2,669 22.0%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 34 34 $11,424 $2,488 21.8%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 13 13 $6,617 $1,588 24.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 25 25 $5,750 $1,467 25.5%
86003 Measurement of antibody (ige) to allergic substance Office 2020 14 224 $3,584 $1,045 29.1%
95004 Injection of allergenic extracts into skin, accessed through the skin Office 2020 12 276 $3,588 $907.27 25.3%
36415 Insertion of needle into vein for collection of blood sample Office 2020 12 15 $120.00 $44.64 37.2%

About Dr. Renganathan Srinivasan, M.D

Dr. Renganathan Srinivasan, M.D is a Allergy & Immunology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396841169.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Renganathan Srinivasan, M.D has received a total of $6,425 in payments from pharmaceutical and medical device companies, with $29.53 received in 2023. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($4,555).

As a Medicare-enrolled provider, Srinivasan has provided services to 431 Medicare beneficiaries, totaling 1,428 services with total Medicare billing of $31,744. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.

Practice Information

  • Specialty Allergy & Immunology
  • Other Specialties Internal Medicine, Allergy & Immunology
  • Location Portland, OR
  • Active Since 09/16/2006
  • Last Updated 12/23/2024
  • Taxonomy Code 207K00000X
  • Entity Type Individual
  • NPI Number 1396841169

Products in Payments

  • NUCALA (Biological) $2,828
  • Odactra (Drug) $1,381
  • Xembify (Biological) $1,152
  • Orladeyo (Drug) $110.00
  • AYVAKIT (Drug) $29.53

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Allergy & Immunology Doctors in Portland